{'fraction_non_alphanumeric': 0.0205799812909261, 'fraction_numerical': 0.0, 'mean_word_length': 5.184971098265896, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The Costs of Implementing the Biosafety Protocol - A Look at China

As countries prepare to take decisions on the Biosafety Protocol’s (BSP) documentation requirements for shipments of living modified organisms (LMOs) intended for food, feed and processing (LMOs-FFP), many questions remain about the appropriate ways that the BSP might be implemented and about its potential impacts. Answers to these questions are particularly important for developing countries that are large importers of agricultural commodities and have the capacity to develop biotechnology products of their own. The International Food and Agricultural Trade Policy Council (IPC) has consistently urged parties to the BSP to assess the likely impacts of the different options. As a developing country that imports large amounts of commodities, China’s experience with regards to the BSP will be of interest to other developing countries as well. For this purpose, the IPC has commissioned a study on the economic impact of the BSP on China to be completed shortly, on which this report is based.